Načítá se...
SIRT2‐mediated inactivation of p73 is required for glioblastoma tumorigenicity
Glioblastoma is one of the most aggressive forms of cancers and has a poor prognosis. Genomewide analyses have revealed that a set of core signaling pathways, the p53, RB, and RTK pathways, are commonly deregulated in glioblastomas. However, the molecular mechanisms underlying the tumorigenicity of...
Uloženo v:
| Vydáno v: | EMBO Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216266/ https://ncbi.nlm.nih.gov/pubmed/30213795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201745587 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|